A Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers

A Phase 1 Multiple Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 Administered Intravenously to Healthy Volunteers

This is a randomized, double-blind, placebo-controlled, multiple-dose study, designed to assess the safety, tolerability, and pharmacokinetics (PK) of ACHN-975. This study will take place in the US at one clinical site.

Key Inclusion Criteria:

• Body weight between 40 and 100 kilograms (between ~88 pounds and ~220 pounds)
• Use of contraception
• Stable health
• Negative tests for alcohol, tobacco, and drugs of abuse

Key Exclusion Criteria:

• History of clinically significant disease
• Pregnancy